Biogen to Present at the 36th Annual J.P. Morgan Healthcare Conference
Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference. The webcast will be live on Monday, January 8, 2018 at 2:30 p.m. PST, 5:30 p.m. EST. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available following the presentation.
About Biogen
Through cutting-edge science and medicine,
Biogen discovers, develops and delivers innovative therapies worldwide
for people living with serious neurological and neurodegenerative
diseases. Founded in 1978, Biogen is a pioneer in biotechnology and
today the Company has the leading portfolio of medicines to treat
multiple sclerosis, has introduced the first and only approved treatment
for spinal muscular atrophy, and is at the forefront of neurology
research for conditions including Alzheimer’s disease, Parkinson’s
disease and amyotrophic lateral sclerosis. Biogen also manufactures and
commercializes biosimilars of advanced biologics. For more information,
please visit www.biogen.com.
Follow us on social media – Twitter,
LinkedIn,
Facebook,
YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171218006040/en/
Biogen
Karen Jewell, 781-464-2442
Investor Relations
